Necrotizing enterocolitis claims against Similac & Enfamil. LeadClient is in active acquisition on this docket — originating claimants through our own media, screening them through our U.S.-based intake, and working each file through pre-litigation.
Plaintiff-pool estimates are our own research, updated quarterly, indicative only.
Currently retaining at scale — campaigns live, intake staffed, and signed claimants delivering into partner-firm caseloads.
Media is bought in your firm's name — you own the account, the pixel, and every claimant record. Qualification runs against your criteria on recorded lines, and every retainer carries a continuous source record from the ad to the signature. Records retrieval, proof of use, and claimant contact continue through filing.
Tell us the tort and the volume you're planning for. We'll tell you exactly how we'd source it.